<DOC>
	<DOCNO>NCT00848432</DOCNO>
	<brief_summary>This study set determine duration maintenance treatment therapeutic risperidone dose schizophrenia . In multi-center , open label , randomize , control study design , patient schizophrenia clinically stabilize follow acute episode randomly assign 'maintenance group ' ( optimal therapeutic dos continue least 1 year ) , 4-week group ( optimal therapeutic dos continue 4 week follow 50 % dose reduction maintain least 11 month ) 26-week group ( optimal therapeutic dos continue 26 week follow 50 % dose reduction least another 6 month ) .</brief_summary>
	<brief_title>Risperidone Maintenance Treatment Schizophrenia</brief_title>
	<detailed_description>Prevention relapse crucial task maintenance treatment schizophrenia . This study set determine duration maintenance treatment therapeutic risperidone dose schizophrenia . In multi-center , open label , randomize , control study design , patient schizophrenia clinically stabilize follow acute episode randomly assign 'maintenance group ' ( optimal therapeutic dos continue least 1 year ) , 4-week group ( optimal therapeutic dos continue 4 week follow 50 % dose reduction maintain least 11 month ) 26-week group ( optimal therapeutic dos continue 26 week follow 50 % dose reduction least another 6 month ) .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>1. outpatient either sex diagnose DSMIV schizophrenia 2. clinically stable follow acute episode least 4 less 8 week , 'clinical stability ' define sum score Brief Psychiatric Rating Scale ( BPRS ) less 36 point 3. age 18 65 year 4. receive risperidone monotherapy titrate optimal level acute phase treatment psychotic episode 5. local resident , live least one family member discharge 6. satisfactory treatment adherence define pill count yield 80 % adherence risperidone prescription past 4 week 7. understand aim study sign consent form 1. take antidepressant , mood stabilizer , Chinese herbal remedy concomitantly risperidone , receive electroconvulsive therapy ( ECT ) , participate drug trial interventional study 4 week study entry 2. history ongoing experience major chronic medical neurological condition ( ) require treatment would likely affect psychic function 3. past current drug/alcohol abuse nicotine 4. pregnant plan become pregnant , lactating , practice effective method birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Maintenance treatment</keyword>
	<keyword>Relapse</keyword>
</DOC>